Cargando…
18F-FDG PET and PET/CT in the Localization and Characterization of Lesions in Patients with Ovarian Cancer
AIM: The aim was to compare the imaging findings of (18)F-fluorodeoxyglucose ((18)F-FDG) PET and integrated PET/CT in patients with primary, recurrent or metastatic ovarian cancer. MATERIALS AND METHODS. 21 women with ovarian cancer were evaluated. All patients had a integrated PET/CT scan. Localiza...
Autores principales: | Caprio, M.G., Capacchione, D., Mainolfi, C., Spera, A.M., Salvatore, B., Cella, L., Salvatore, M., Pace, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università di Salerno
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728776/ https://www.ncbi.nlm.nih.gov/pubmed/23905042 |
Ejemplares similares
-
Staging recurrent ovarian cancer with (18)FDG PET/CT
por: DRAGOSAVAC, SANJA, et al.
Publicado: (2013) -
Is 2-deoxy-2-[(18)F]fluoro-D-glucose PET/CT acquisition from the upper thigh to the vertex of skull useful in oncological patients?
por: Salvatore, B., et al.
Publicado: (2014) -
Brain Metastases Unresponsive to Immunotherapy Detected by 18F-FDG-PET/CT in a Patient with Melanoma
por: Fonti, Rosa, et al.
Publicado: (2020) -
[(18)F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging
por: Aiello, Marco, et al.
Publicado: (2020) -
Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)